Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease

American Heart Journal

Volumn 155, Issue 4, 2008, Pages 772-779

  Ho, P Michael ^a,b,c   Magid, David J ^b,c   Shetterly, Susan M ^c   Olson, Kari L ^b,d   Maddox, Thomas M ^a,b,c   Peterson, Pamela N ^b,c,e   Masoudi, Frederick A ^b,c,e   Rumsfeld, John S ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Clinical Research Unit   (United States)

^d Clinical Pharmacy Cardiac Risk Service   (United States)

^e DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT REFUSAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL REVASCULARIZATION; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT REFUSAL;

EID: 40949131340     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.12.011     Document Type: Article

References (26)

1. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guidelines update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients With Chronic Stable Angina) (2002)
2. Krumholz H.M., Anderson J.L., Brooks N.H., et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 47 (2006) 236-265
3. Physician Consortium for Performance Improvement. Clinical performance measures: chronic stable coronary artery disease. http://www.acc.org/clinical/measures/intro.htm [Accessed on January 5. 2006] Chicago IL: American Heart Association
4. Burwen D.R., Galusha D.H., Lewis J.M., et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the Medicare health care quality improvement program. Arch Intern Med 163 (2003) 1430-1439
5. Gislason G.H., Abildstrom S.Z., Rasmussen J.N., et al. Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002. Scand Cardiovasc J 39 (2005) 42-49
6. Ho P.M., Magid D.J., Masoudi F.A., et al. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord 6 (2006) 48
7. Newby L.K., LaPointe N.M.A., Chen A.Y., et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 113 (2006) 203-212
8. Benner J.S., Glynn R.J., Mogun H., et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 288 (2002) 455-461
9. Gislason G.H., Rasmussen J.N., Abildstrom S.Z., et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 27 (2006) 1153-1158 [Electronic publication 2006 Jan 6]
10. Simpson S.H., Eurich D.T., Majumdar S.R., et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ (2006)
11. Olson K.L., Rasmussen J., Sandhoff B.G., et al. Clinical Pharmacy Cardiac Risk Service Study Group. Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Arch Intern Med 165 (2005) 49-54
12. Sandhoff B.G., Nies L.K., Olson K.L., et al. Clinical Pharmacy Cardiac Risk Service: guidelines and practices in a population approach to managing patients with coronary artery disease. Am J Health Syst Pharm 64 (2007) 77-84
13. Chapman R.H., Benner J.S., Petrilla A.A., et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 165 (2005) 1147-1152
14. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med 353 (2005) 487-497
15. Lau D.T., and Nau D.P. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 27 (2004) 2149-2153
16. Wei L., Wang J., Thompson P., et al. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 88 (2002) 229-233
17. Wei L., Flynn R., Murray G.D., et al. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?. Pharmacoepidemiol Drug Saf 13 (2004) 761-766
18. Rasmussen J.N., Chong A., and Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297 (2007) 177-186
19. Blackburn D.F., Dobson R.T., Blackburn J.L., et al. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 21 (2005) 485-488
20. Jackevicius C.A., Mamdani M., and Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288 (2002) 462-467
21. Lee J.K., Grace K.A., and Taylor A.J. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 296 (2006) 2563-2571 [Electronic publication 2006 Nov 13]
22. Friedman R.H., Kazis L.E., Jette A., et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 9 4 Pt 1 (1996) 285-292
23. Piette J.D., Kraemer F.B., Weinberger M., et al. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System. Diabetes Care 24 (2001) 202-208
24. Piette J.D. Interactive voice response systems in the diagnosis and management of chronic disease. Am J Manag Care 6 (2000) 817-827
25. Crossing the quality chasm: a new health system for the 21st century, the Committee on Quality of Health Care in America, Institute of Medicine (2001), National Academy Press, Washington (DC)
26. Ho P.M., Rumsfeld J.S., Masoudi F.A., et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 166 (2006) 1836-1841